A consideration of control requirements for acellular pertussis vaccines.
Corbel
M J
MJ
National Institute for Biological Standards and Control, Potters Bar, UK.
Xing
D K
DK
D018829:Adhesins, Bacterial / Q000276:immunology; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000276:immunology / Q000592:standards*; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D004355:Drug Stability; D010861:Fimbriae, Bacterial / Q000276:immunology; D006388:Hemagglutinins / Q000276:immunology; D006801:Humans; D051379:Mice; D011786:Quality Control; D010566:Virulence Factors, Bordetella; D014917:Whooping Cough / Q000517:prevention & control*
D018829:Adhesins, Bacterial; D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D006388:Hemagglutinins; D010566:Virulence Factors, Bordetella; C065273:filamentous hemagglutinin adhesin, Bordetella pertussis; C068929:pertactin